These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27482863)

  • 1. Cardiovascular Disease Risk in Psoriatic Arthritis-Common Soil Due to Proinflammatory State and Autoimmune Activation: Comment on the Article by Polachek et al.
    Onat A; Altay S; Karakoyun S
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):456-457. PubMed ID: 27482863
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis: comment on 'Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review' by Jamnistki et al.
    González-Gay MA; González-Juanatey C; Llorca J; Castañeda S
    Ann Rheum Dis; 2014 May; 73(5):e27. PubMed ID: 24442882
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the classification criteria for psoriatic arthritis better than existing criteria for diagnosing psoriatic arthritis? Comment on the article by Taylor et al.
    McGonagle D; Tan AL
    Arthritis Rheum; 2007 Feb; 56(2):699-700; author reply 700. PubMed ID: 17265515
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: Cardiovascular risk in psoriatic arthritis; should we focus on hypertension and diabetes only? Gkaliagkousi et al.
    Favarato MH; Goldenstein-Schainberg C
    Clin Exp Rheumatol; 2014; 32(6):996. PubMed ID: 25233825
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec
    Wei CY; Lee YH; Wei JCC
    Ann Rheum Dis; 2022 Aug; 81(8):e138. PubMed ID: 32873556
    [No Abstract]   [Full Text] [Related]  

  • 6. Does early and aggressive treatment improve the prognosis in psoriatic arthritis? Comment on the article by Wong et al.
    Brockbank J; Leach M; Snaith M; Adebajo A
    Arthritis Rheum; 1999 Jan; 42(1):189. PubMed ID: 9920032
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al.
    Nurmohamed MT; Jamnitski A; Symmons D; Peters MJ; Sattar N; McInnes I
    Ann Rheum Dis; 2014 May; 73(5):e28. PubMed ID: 24577335
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
    Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is juvenile psoriatic arthritis? Comment on the article by Stoll et al.
    Martini A
    Arthritis Rheum; 2007 Apr; 56(4):1368. PubMed ID: 17393443
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional Significance of Interleukin-9 and Its Receptor System in the Pathogenesis of Psoriatic Arthritis: Comment on the Article by Ciccia et al.
    Raychaudhuri SK; Abria C; Raychaudhuri SP
    Arthritis Rheumatol; 2017 Feb; 69(2):472-473. PubMed ID: 27768837
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of psoriatic nail disease activity by rheumatologists: comment on the article by Lubrano et al.
    Kavanaugh A
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1269; author reply 1269-70. PubMed ID: 22623218
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoriatic arthritis--an enthesopathy-based disorder? Comment on the article by McGonagle et al.
    Costello P; Kane D; Curran S; Bresnihan B; FitzGerald O; Winchester R
    Arthritis Rheum; 2000 Mar; 43(3):712-4. PubMed ID: 10728773
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut-brain axis dysfunction may be associated with psoriatic arthritis: comment on the article by Scher et al.
    Lu L; He L
    Arthritis Rheumatol; 2015 May; 67(8):2280. PubMed ID: 25919422
    [No Abstract]   [Full Text] [Related]  

  • 14. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
    Yim KM; Armstrong AW
    Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation?
    Kristensen SL; McInnes IB; Sattar N
    Ann Rheum Dis; 2015 Feb; 74(2):321-2. PubMed ID: 25429028
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply.
    Polachek A; Touma Z; Anderson M; Eder L
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):457. PubMed ID: 27482649
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-Lyme Arthritis May Be More Than Lyme: Comment on the Article by Arvikar et al.
    Tuttle C
    Arthritis Rheumatol; 2017 Mar; 69(3):684. PubMed ID: 27863157
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis.
    Bergman M; Lundholm A
    Arthritis Res Ther; 2017 Mar; 19(1):63. PubMed ID: 28320454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk factors in psoriatic and rheumatoid arthritis].
    Rebrov AP; Nikitina NM; Gaĭdukova IZ
    Ter Arkh; 2011; 83(5):20-4. PubMed ID: 21780652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.